1 Million Copies Sold — ‘The Real Anthony Fauci’ — BUY TODAY!

Covid News Watch

May 13, 2021

COVID Vaccines May Not Protect People With Immune Disorders + More

COVID Vaccines May Not Protect People With Immune Disorders. NIH Trial Seeks Answers.

NBC News reported:

Millions of Americans have immune disorders or autoimmune diseases — such as lupus, rheumatoid arthritis or Crohn’s disease — that require them to take immune-suppressing treatments for life. Because people with compromised immune systems were largely excluded from the COVID-19 vaccine trials in the U.S. and globally, it’s unknown how much protection they get from vaccination.

A recent study by researchers at Johns Hopkins University found that only half of organ transplant recipients developed antibodies after two doses of a Covid-19 vaccine.

CDC Says It’s Ok to Get a COVID-19 Vaccine Alongside Other Vaccines

CNN Health reported: 

A U.S. Centers for Disease Control and Prevention expert said Wednesday that it’s OK to give the coronavirus vaccine alongside other vaccinations, a major boon for children and teenagers behind on their regular inoculations.

Doctors and other clinicians were previously advised to avoid giving coronavirus vaccine within two weeks of any other vaccine. But Dr. Kate Woodworth of the CDC’s birth defects division said Wednesday that advice has now changed, saying there is substantial data on the safety of the vaccines.

Get Vaccinated in Ohio and Get a Shot at $1 Million, Gov. Mike DeWine Announces

NBC News reported:

Ohio Gov. Mike DeWine on Wednesday announced a novel incentive program for people in his state to get vaccinated — a $1 million lottery.

DeWine, a Republican, said only people who’ve gotten the vaccine will be eligible to win the prize, which will be paid for by federal coronavirus funds.

“Two weeks from tonight on May 26th, we will announce a winner of a separate drawing for adults who have received at least their first dose of the vaccine. This announcement will occur each Wednesday for five weeks, and the winner each Wednesday will receive one million dollars,”DeWine said in a series of tweets.

‘Plausible’ Link Between J&J Vaccine and Blood Clots, CDC Says After Confirming 28 Cases, Including 3 Deaths

The Defender reported:

Officials with the Centers for Disease Control and Prevention (CDC) said Wednesday they see a “plausible causal association” between the Johnson & Johnson COVID vaccine and potentially life-threatening blood clot disorders after identifying 28 cases — including three deaths — among people who received the vaccine.

Dr. Tom Shimabukuro, deputy director of the CDC’s immunization safety office, presented the new cases at a Wednesday meeting of CDC panel advisers, The New York Times reported.

Tens of Thousands of Lives Could Have Been Saved if Research on COVID Treatments Hadn’t Been Suppressed, Doctors and Economists Say

The Defender reported:

Since the first days of the declared coronavirus pandemic, doctors faithful to their Hippocratic Oath have been searching for — and identifying — effective COVID-19 treatments.

In mid-November, Dr. Peter McCullough, vice chief of internal medicine at Baylor University Medical Center, and three other experts outlined safe and available treatments for the Senate’s influential Homeland Security & Governmental Affairs Committee.

University of Wisconsin critical care specialist Dr. Pierre Kory followed up with more discussion of viable COVID treatments at a Dec. 8 appearance before the same committee.

However, as Children’s Health Defense Chairman Robert F. Kennedy, Jr. observed during a March 2021 conversation with McCullough, “we’ve seen this very strange conflict … that many of those treatments that could save lives, instead of being promoted and investigated and studied by the health authorities, are instead being sabotaged and made … inaccessible.”

Tennessee Woman Partially Paralyzed After Rare Reaction to COVID Vaccine Walks Again

NBC4 reported:

Brandy Parker-McFadden walks with a purpose.

“My biggest motivation was to get home to my kids and my husband,” Parker-McFadden said.

Each small, slow step is a part of the story of the Nashville woman’s journey that started nearly four weeks ago when doctors say Parker-McFadden had an extremely rare reaction to Pfizer’s COVID-19 vaccine that left her unable to move her legs. The therapy team wasn’t sure if she’d walk again.

Americans as Young as 12 Begin to Get Vaccinated Against COVID-19 After FDA’s Authorization

CNN health reported:

Some vaccine sites began to inoculate 12-to-15-year-olds against COVID-19 on Tuesday morning, a day after the U.S. Food and Drug Administration authorized Pfizer’s vaccine for the age group.

Jacob Laney, 14, was in line at a Decatur, Georgia, vaccine site early Tuesday in hopes of getting the vaccine …

The shots are somewhat premature, as doctors are technically not supposed to start administering the vaccine to this age group until the U.S. Centers for Disease Control and Prevention recommends they do so.

WATCH: Dr. Walensky Encourages Youth to Ask for Vaccine

PBS reported:

The director for the Centers for Disease Control and Prevention is “encouraging children to ask for the vaccine” after regulators on Monday expanded the use of Pfizer’s COVID-19 vaccine to children as young as 12 …

“I would encourage all parents to get their children vaccinated,” said Dr. Rochelle Walensky during a Senate hearing on Tuesday.

“I have a 16 year old myself and I can tell you he wanted to get the vaccine. He wants his life back. These kids want to go back to school. They want to go back to the things they love.”

Despite FDA Approval, Some Schools Say They Won’t Mandate COVID Vaccinations

CNBC reported:

Now that Pfizer’s COVID vaccine has been approved for children ages 12 to 15, more schools may be able to reopen fully in person this fall.

Yet the question remains whether schools will require students to get vaccinated.

“It’s always better to reinforce positive behavior rather than mandate,” said Bob Bollinger, a professor of infectious diseases at the Johns Hopkins University School of Medicine and inventor of the emocha Health app. “But we have a precedent of requiring vaccinations to go to school.”

Yankees Dealing With COVID-19 Issues as Seven Members of Traveling Party Test Positive

CBS Sports reported:

The New York Yankees have had seven members of their traveling party test positive for COVID-19, according to manager Aaron Boone’s pregame comments on Wednesday. Three of the seven positive tests came from coaches and the other four are support staff members. All seven members had previously been vaccinated, and six of the cases are considered asymptomatic in nature, Boone noted. The Yankees had previously had two coaches and one support staff member test positive for COVID-19 ahead of their series opener against the Rays in St. Petersburg on Tuesday.

Here’s What a Moderna Executive Said About the Possibility of a COVID-19 Booster Shot

The Boston Globe via MSN reported:

Moderna’s chief executive on Wednesday discussed the biotech’s progress in developing a booster shot against COVID-19 variants, saying the company hopes to have authorization from the Food and Drug Administration on one of three booster strategies by the end of the summer or early fall.

Speaking from the company’s Norwood facility during a press briefing with Governor Charlie Baker, Stéphane Bancel said Moderna is working on three different options for a single-dose booster shot against variants of concern: the current vaccine, a new variant-specific vaccine, and a 50/50 mix of the two.

Merck, GSK and Pfizer Vaccines Get a Boost as CDC Lifts Two-Week Restriction on Pandemic Shots

FiercePharma reported:

As revenues for several Big Pharma players slumped to start the year, execs blamed part of the problem on the accelerating COVID-19 vaccine rollout. The CDC had recommended people don’t get another shot within two weeks of their COVID-19 vaccine, hitting sales for key products.

Now, the CDC is doing away with that suggestion entirely in an effort to boost routine immunizations among teens. The move could spell financial rewards for leading vaccine companies such as Merck, GlaxoSmithKline and Pfizer.

During the CDC’s Advisory Committee on Immunization Practices (ACIP) meeting on Wednesday, experts endorsed the COVID-19 shot from Pfizer and BioNTech in adolescents aged 12 to 15 and additionally tossed out the agency’s two-week restriction on administering other vaccines.

CDC’s Slow, Cautious Messaging on COVID-19 Seems Out of Step With the Moment, Public Health Experts Say

STAT News reported:

Nearly a year ago, amid concerns about how to prevent transmission of the virus causing COVID-19, scientists were beginning to conclude that rigorous disinfection of surfaces — say, fogging them or deep-cleaning with bleach — was overkill.

Academics were warning that the risk of so-called fomite transmission was wildly overblown. In the fall, research from Israel and Italy found that the virus couldn’t even be cultured from surfaces in hospital infectious disease units. By February of this year, the editorial board of Nature was openly urging the Centers for Disease Control and Prevention to update its guidelines.

The CDC did so — last month.

More Frequent Side-Effects Reported Mixing Pfizer and Oxford COVID Jabs, Study Suggests

The Guardian reported:

Administering one dose of the Pfizer/BioNTech vaccine followed by one of the Oxford/AstraZeneca vaccine (or vice versa) induces a higher frequency of mild to moderate side-effects compared with standard two doses of either vaccine, initial data from a key UK trial suggests.

The Oxford-led Com-Cov study is exploring the safety and efficacy of mixed-dose schedules given that they are being considered in several countries – including the UK – to fortify vaccine rollout programmes that are dependent on unstable vaccine supplies.

May 12, 2021

CDC Recommends Pfizer Vaccine for Kids as Young as 12 + More

CDC Panel Recommends Pfizer’s COVID-19 Vaccine for Kids as Young as 12

USA TODAY reported:

Adolescents ages 12 to 15 should get the Pfizer-BioNTech COVID-19 vaccine and they can get their other routine vaccinations along with it, a federal advisory committee said Wednesday.

The Centers for Disease Control and Prevention’s panel met to discuss the safety, immune response and effectiveness of the vaccine in this age group, after the Food and Drug Administration signed off Monday on the shots.

McDonald’s to Promote Vaccine Information on Coffee Cups While Uber and Lyft to Give Free Rides to Vaccine Sites

The Guardian reported:

Incentivizing the vaccine-hesitant in America has reached the fast food and ride-share industries.

Burger chain McDonald’s has announced it is partnering with the White House to promote vaccination information on its coffee cups.

Separately, Joe Biden announced on Tuesday a new program with Lyft and Uber which will offer free rides to anyone going to a vaccination site to get vaccinated.

17-Year-Old in Prince George’s County Mistakenly Given the Moderna Vaccine

WSUA9 CBS News reported:

A 17-year-old in Prince George’s County said she was mistakenly given the Moderna shot and has since struggled to get her second dose.

Ozioma Ahaghotu jumped at the chance to sign up for her COVID shot when Maryland opened vaccinations to teens.

Yankees Coach Phil Nevin Tests Positive For COVID-19 in ‘Breakthrough’ Case

New York Post reported:

Yankees third base coach Phil Nevin has tested positive for COVID-19, the team announced before Tuesday’s game against the Rays, calling it a “breakthrough positive” since Nevin had been fully vaccinated.

Manager Aaron Boone said there are other staff members and coaches “still pending,’’ and some staff members had been sent home. Nevin was under quarantine in Tampa.

Brazil Suspends AstraZeneca Vaccine After Pregnant Woman Dies, New Study Links Vaccine to Blood Clots, More Countries Hit Pause

The Defender reported:

More countries are restricting AstraZeneca’s COVID vaccine as reports of blood clots mount, and a new study published in The BMJ linked the vaccine to a higher-than-expected risk of blood clots.

Brazil’s federal government on Tuesday suspended AstraZeneca’s vaccine for pregnant women after an expectant mother in Rio de Janeiro died from a stroke possibly related to the vaccine, Reuters reported. The 35-year-old woman, who was 23 weeks pregnant, died of a hemorrhagic stroke on Monday after checking into a hospital five days earlier.

As COVID Vaccines Drive Record Profits, CEOs Get Ultra Rich Off Massive Pay Packages, Questionable Stock Sales

The Defender reported:

As pharmaceutical companies make billions from COVID vaccines and reassure investors that plans are underway for boosters and annual shots, CEOs of Pfizer, Moderna, AstraZeneca and Johnson and Johnson (J&J) are pocketing millions with massive compensation packages and questionable stock sales.

In his weekly notes to investors last month, Bernstein analyst Ronny Gal offered shocking revenue estimates for Pfizer and Moderna’s mRNA vaccines — $24 billion in revenue for Pfizer compared with $14 billion for Moderna.

By the fourth quarter, Gal and his team project industrywide COVID vaccine revenues reaching more than $18 billion per quarter. The Pfizer-BioNTech and Moderna shots will account for roughly $11 billion of that amount with the remaining revenue split equally between J&J, AstraZeneca and Novavax, Fierce Pharma reported.

WHO Stands by Vaccines as It Sounds Alarm on India COVID Variant, Scientist Warns Mass Vaccination May Cause More Infectious Strains

The Defender reported:

The World Health Organization (WHO) Monday elevated India’s COVID variant B.1.617 from a “variant of interest” to a “variant of global concern.” The variant, which was first isolated in India, is believed to be driving the country’s brutal second wave.

In a follow-up statement today, the WHO said the B.1.6.1.7 variant has since spread throughout India and at least “44 countries in all six WHO regions.”

Maria Van Kerkhove, the WHO’s technical lead for COVID, said during Monday’s press conference new data under peer review shows B.1.617 is more transmissible than earlier strains of the virus.

Astrazeneca Runs Into ‘Meaningful’ Investor Revolt Over Pay

Reuters reported:

 AstraZeneca said a “meaningful proportion” of its shareholders voted against CEO Pascal Soriot’s improved pay package on Tuesday, exposing a rift as the drugmaker deals with problems surrounding its COVID-19 vaccine.

At its annual investor meeting, 60.19% of votes cast were in favor, AstraZeneca said, adding that it would “engage and listen to ensure investors’ concerns regarding the approach to executive remuneration are understood.”

Large corporations typically win about 90% support for their pay in annual advisory votes, compensation consultants say, making narrow-win results such as AstraZeneca’s effectively a call to review the program and talk to shareholders.

Pharma Industry’s Reputation Hits Plateau Amid Spike in Vaccine Hesitancy

FiercePharma reported:

Pharma’s hockey-stick improvement in reputation is flattening out. The good news is the industry is still the biggest gainer amid the pandemic, according to The Harris Poll’s most recent survey.

Sixty percent of Americans rate the pharma industry positively, down slightly from a 62% high in February. But that’s still an increase of 28 percentage points since January 2020, before the pandemic began.

The less-good news, though, is that pharma’s stall comes as other industries continue to polish their reputations. Retail grocery, technology and consumer products were the highest-rated industries in the early May poll and are on the upswing.

Pfizer, Regeneron CEOs See Extended Need for COVID-19 Vaccines, Treatments as Pandemic Enters Next Phase

FiercePharma reported:

Pharma companies with COVID-19 vaccines and drugs have reeled in big sales in recent months, but even as vaccines promise to eventually tackle the pandemic, eye-popping revenue figures will continue for quite some time, execs project.

Pfizer CEO Albert Bourla has flagged the likely need for vaccine boosters as the pandemic continues to evolve. On a recent conference call with analysts, he said that “basically all governments of the world are now discussing with us about procurement agreements” for 2022, 2023 and 2024. In fact, Europe just signed a massive agreement for up to 1.8 billion doses from Pfizer and BioNTech through 2023.

Patients are “likely” to need a third dose of Pfizer and BioNTech’s shot once the period of initial protection wanes, CEO Albert Bourla said in a recent interview with CVS Health Live. The comments came shortly after Pfizer posted data showing Comirnaty was 91.3% effective against symptomatic COVID-19 for up to six months in patients who’d received their second dose.

May 11, 2021

FDA Authorizes Pfizer Vaccine for Ages 12-15 + More

FDA Authorizes Pfizer Vaccine for 12-15-Year-Olds

ABC News reported:

The Pfizer vaccine has been authorized for children ages 12 and up, widening the U.S. population that will be protected against the virus and bolstering chances for a safe return to full-time school in the fall, the Food and Drug Administration announced Monday.

“We know this is a big step for our country. Vaccinating a younger population brings us closer to returning to a sense of normalcy and to ending the pandemic,” acting FDA Commissioner Janet Woodcock said at a press briefing on Monday night.

Woodcock said parents and guardians can “rest assured that in making our decision, the agency undertook a rigorous and thorough review of all available scientific data, as we have with all the COVID-19 vaccine authorizations.”

Pfizer Vaccine Could Be Available For Ages 2 and Up as Early as This Fall, Exec Says

CBS News reported:

Data from Pfizer’s coronavirus vaccine trials in children aged two years and older could be available as early as this fall, Pfizer’s Senior Vice President of Vaccine Clinical Research and Development Dr. William Gruber said, possibly paving the way for use before the end of 2022.

The drugmaker is also conducting clinical trials on their vaccine for babies aged six months and older. Gruber anticipates data from those trials will likely be available “late at the end of the year or beginning of 2022.”

64 Days and Counting — Why Won’t the CDC Answer Our Questions?

The Defender reported:

On March 8, The Defender contacted the Centers for Disease Control and Prevention (CDC) with a written list of questions about reported deaths and injuries related to COVID vaccines. We requested information about how the CDC conducts investigations into reported deaths, the status of ongoing investigations into deaths and injuries reported by the media, if autopsies were being conducted, the standard for determining whether an injury is causally connected to a vaccine, and education initiatives to encourage and facilitate proper and accurate reporting …

It has been 64 days since we sent our first email inquiring into VAERS data and reports, but still no response.

Patients Died From Neglect, Not COVID-19, in Ontario LTC Homes, Military Report Finds

The Globe and Mail reported:

Dozens of residents in two Ontario nursing homes hit hard by the coronavirus died not from COVID-19 but from dehydration and neglect, the Canadian military says in reports obtained by The Globe and Mail.

The documents contain new details about the deplorable conditions in two Toronto homes before the Forces stepped in last year, revealing for the first time that causes other than COVID-19 hastened the deaths of residents as outbreaks spiralled out of control and staffing collapsed.

At Downsview Long Term Care Centre, where one in four residents succumbed to the virus, another 26 died from dehydration before a military team arrived last June to provide humanitarian and medical support.

Why FDA Should Not Authorize COVID Vaccines for Kids, Teens

Medium reported:

For adults, the benefits of COVID-19 vaccination are enormous, while for children, they are relatively minor. Rare side effects from adult COVID-19 vaccination are unlikely to lead to future vaccine hesitancy whose public health impact could be comparable to the benefits of the adult COVID-19 vaccination program itself.

But accelerated mass child vaccination under Emergency Use Authorization — perhaps even spurred by school mandates and “vaccine passports” — presents a different balance of risks and benefits. Rare adverse events really could prove to be the most durable public health legacy of an EUA for child COVID-19 vaccines.

Slovakia Suspends Use of Astrazeneca COVID-19 Vaccine as a Recipient Dies

Reuters via Yahoo! News reported:

Slovakia’s Health Ministry said on Tuesday it was suspending the use of AstraZeneca’s COVID-19 vaccine for people getting their first doses, after experts reviewed the death of a recipient.

The state drug regulator, SUKL, said last week that the death of a 47-year-old woman was likely to be connected to the vaccine because of a predisposition that she had.

“The Health Ministry is considering various options at the moment, how to proceed with this issue,” spokeswoman Zuzana Eliasova said. “At the moment, people waiting for their second dose are being inoculated with the AstraZeneca vaccine.”

A Misleading CDC Number

The New York Times reported:

When the Centers for Disease Control and Prevention released new guidelines last month for mask wearing, it announced that “less than 10 percent” of COVID-19 transmission was occurring outdoors. Media organizations repeated the statistic, and it quickly became a standard description of the frequency of outdoor transmission.

But the number is almost certainly misleading.

It appears to be based partly on a misclassification of some COVID transmission that actually took place in enclosed spaces (as I explain below). An even bigger issue is the extreme caution of CDC officials, who picked a benchmark — 10 percent — so high that nobody could reasonably dispute it.

Brazil Agency Calls for Suspending AstraZeneca Vaccine for Pregnant Women

The Wall Street Journal reported:

Brazil’s health authority Anvisa has called for the immediate suspension of the use of AstraZeneca’s COVID-19 vaccine among pregnant women in the Latin American country.

Anvisa said late Monday that its recommendation was the result of “constant monitoring of adverse events related to Covid vaccines in use in the country,” without giving further details.

May 10, 2021

States Turn Down Hundreds of Thousands of Vaccine Doses + More

States Turn Down Hundreds of Thousands of Vaccine Doses

The New York Times reported:

Several states are turning away COVID vaccine doses from their federal government allocations, as the daily average of coronavirus vaccine doses administered across the United States has fallen below two million for the first time since early March. Experts say the states’ smaller requests reflect a steep drop in vaccine demand in the United States.

Wisconsin officials have asked for just 8 percent of the 162,680 doses the federal government had set aside for the state next week, according to The Associated Press. In Iowa, officials asked for just 29 percent of the state’s allocated doses. And in Illinois, the state is planning to request just 9 percent of its allotted doses for everywhere, except for Chicago, for next week, The A.P. reported.

North Carolina, South Carolina, Washington State and Connecticut are also scaling back on their vaccine requests.

Teen Hospitalized With Blood Clots in Brain After First Dose of Pfizer Vaccine

The Defender reported:

A Utah teen remains hospitalized with three blood clots in and near his brain that developed after he received the first dose of Pfizer’s COVID vaccine.

Everest Romney, 17, received the vaccine April 21 and began experiencing neck pain, fever and severe headaches one day later. His mother, Cherie Romney, said her son’s pediatrician initially dismissed the symptoms as a pulled neck muscle. However, she was convinced it was something else, ABC4 News reported.

After more than a week of symptoms and being unable to freely move his neck, the family got this diagnosis: two blood clots inside his brain, and one on the outside.

After Vaccine Safety Review, EU Regulators Call on Pfizer, Moderna, AstraZeneca for More Data on Heart Inflammation, Guillain–Barré Syndrome

The Defender reported:

EU regulators Friday called on Pfizer and Moderna to provide additional data related to the companies’ COVID vaccines and a potential link to heart inflammation, after the agency completed a safety review of all four COVID vaccines authorized for emergency use in the EU.

The European Medicines Agency’s safety committee, (PRAC), also asked AstraZeneca for data related to reports of Guillain–Barré syndrome in people who received the AstraZeneca vaccine, and they recommended Pfizer and Johnson & Johnson (J&J) update their labels with side effect warnings.

In a report issued May 7, PRAC disclosed its members were aware of cases of myocarditis and pericarditis following Pfizer vaccination. Regulators said they didn’t see an indication the vaccine caused these cases, but as a prevention, PRAC requested Pfizer provide further data, including an analysis of events according to age and gender in its next pandemic summary safety report and will consider if any other regulatory action is needed.

FDA Approval of Pfizer Vaccine Could Lead to Vaccine Mandates

WTVR CBS News reported:

 On Friday, Pfizer became the first COVID-19 vaccine producer to request full FDA approval. Virginia’s Vaccination Coordinator Dr. Danny Avula anticipated that approval would have several implications, including the possibility of more vaccination mandates across the country.

The Pfizer vaccine, along with Moderna and Johnson and Johnson, were currently operating under Emergency Use Authorization due to the pandemic.

“This is just the final formal step that Pfizer should take,” said Dr. Melissa Viray, Deputy Director for the Richmond and Henrico Health Districts. “We want this vaccine to be around, even when there isn’t a public health emergency.”

White House, State Officials Scramble to Get Docs’ Help With Lagging Vaccination Effort

Politico reported:

The Biden administration and state health officials are rushing to overcome logistical hurdles to get more COVID-19 shots into doctors’ offices, believing that physicians who have largely been excluded from the inoculation effort so far could be key to boosting vaccination rates.

For months, doctors have lobbied the White House and states to ship them doses, but officials instead focused their efforts on mass vaccination sites and other places that could quickly immunize hundreds or even thousands of people daily. With demand for shots now slipping faster than health experts expected, officials are now trying to steer doses to smaller, local sites like doctor offices that can make targeted efforts to reach people who are hesitant to get vaccinated or have faced other obstacles like lack of transportation.

CDC Admits the Coronavirus Is Airborne, Can Be Transmitted More Than 6 Feet Away

Slate reported:

The Centers for Disease Control and Prevention is finally acknowledging something that health experts have been saying for a while now: COVID-19 spreads through the air and can be inhaled by someone who is more than six feet away. The CDC said in a document published Friday that it has “repeatedly documented” instances of the virus spreading through the air to people who were more than six feet away “under certain preventable circumstances.” This marks a change for the agency that previously said most infections took place through “close contact, not airborne transmission.”

“COVID-19 spreads when an infected person breathes out droplets and very small particles that contain the virus. These droplets and particles can be breathed in by other people or land on their eyes, noses, or mouth. In some circumstances, they may contaminate surfaces they touch. People who are closer than 6 feet from the infected person are most likely to get infected,” the CDC now says on its website.

Woman Accidentally Vaccinated With Six Pfizer Doses

Newsweek via MSN reported:

A 23-year-old woman in Italy‘s central Tuscany region was accidentally administered six doses of the Pfizer vaccine on Sunday, but ended up discharged after 24 hours when she did not appear to suffer any severe effects.

The woman, a clinical psychology trainee in the town of Massa, was scheduled to receive her first dose of the vaccine as a health worker, according to the news agency Agenzia Giornalistica Italia (AGI). But instead of being given a single Pfizer dose, she was accidentally injected with an entire vial — which amounts to six doses.

Poll Finds Many Parents Hesitant to Get Younger Children Vaccinated

HealthDay reported:

Only 29% of parents of children younger than 18 years said they would get their child vaccinated “right away,” according to data published Thursday by the Kaiser Family Foundation. Another 32 percent said they would wait to see how the vaccine is working before getting their child a shot, while the remaining parents said their child would be vaccinated only if their school requires it (15%) or they definitely would not be vaccinated (19%).

In Thursday’s Kaiser survey, parents’ intentions for their children typically mirrored their intentions for themselves. Among parents who have already received at least one dose or want it as soon as possible, three-fourths said they would get their children vaccinated right away (48%) or wait and see (29%).

N.J. Gov. Murphy Open to Paying People to Get COVID-19 Vaccine

Fox News reported:

New Jersey Gov. Phil Murphy says the state is considering paying people to get the COVID-19 vaccine.

“We might, I think all things are on the table frankly,” Murphy told FOX 5 New York in an interview. “We have to get to our objective, which is 70% of the adult population by the end of June.”

Last week, Murphy launched the “Operation Jersey Summer” campaign, which is aimed at helping the state reach its vaccination goal.

Novavax Reports Promising Early Study of Combined COVID-19, Flu Vaccine

The Hill reported:

Vaccine maker Novavax said Monday that an early study in animals of a combination COVID-19 and flu vaccine produced a positive immune response.

The combination vaccine produced “robust” antibody responses to both coronavirus and the flu in a study in ferrets, the company said. The shot is still early in the process, and the company said clinical trials in humans “are expected to begin by the end of the year.”

Expert Panel Calls On Norway To Ditch AstraZeneca And Johnson & Johnson COVID Vaccines Over Blood Clot Risks

Forbes reported:

An expert panel in Norway recommended the country drop vaccines made by AstraZeneca and Johnson & Johnson from its COVID-19 immunization campaign due to a small risk of rare blood clots, the group announced Monday, a decision that could potentially set back the country’s efforts to offer a shot to all adults by a month.

A raft of countries halted AstraZeneca and Johnson & Johnson vaccine rollouts over the past few weeks, following reports of very rare blood clotting. Regulators in Europe, the U.S. and the World Health Organization determined that there is a rare risk of clotting, though overwhelmingly said the vaccines’ benefits outweigh any possible risks of blood clotting. A number of countries — including France, Germany, the U.K. and Canada — have restricted the shot to older populations, who are believed to be less at-risk of clotting. Denmark has stopped using them entirely despite rising COVID-19 infections.